Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Stocks Trader Talk -- Ignore unavailable to you. Want to Upgrade?

To: NCKEV who wrote (473)	3/7/2002 8:04:59 PM
From: Michael Young	Respond to of 787

I'll probably sell tomorrow, and look to get back in around $15. SEPR will have around $200 million in revenues in 2002. Fast growing biotechs often trade around 10 x sales. The market cap today is around $1.6 billion. The psychologicl blow is devastating. Even biotech short sellers largely didn't anticipate any FDA problems with Soltara. It was widely expected to be a billion dollar drug in a few years, with gross margins over 80%. MIKE MIKE